XML 24 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated statements of cash flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities    
Net income (loss) $ (110,780) $ 282
Adjustments for:    
Depreciation of property and equipment (Note 7) 3,153 884
Depreciation of right-of-use assets (Note 8) 3,308 2,513
Amortization of intangible assets (Note 9) 31,609 12,063
Amortization of development costs (Note 10) 1,281 1,370
Income tax expense (Note 11) 6,390 4,102
Income tax paid (2,752) (3,088)
Income tax refunds 1,197 478
Share-based compensation expense (Note 17(ii)) 9,929 3,758
Interest on obligation on right-of-use assets (Note 8) 442 374
Unrealized foreign exchange gain (loss) 174 (1,012)
Goodwill Impairment (Note 12) 91,685  
Accretion expense (Note 14) 798  
Gain on lease modification (Note 8) (105)  
Loss on disposal of property and equipment (Note 7) 266 133
Gain on change in fair value of consideration payable (Note 14) (2,254) (4,167)
Changes in working capital    
Trade receivables 1,555 (928)
Inventories (5,190) (1,094)
Contract assets (2,198) (800)
Other assets (611) (51)
Sales tax payable (930) 726
Accounts payable and accrued liabilities (3,234) 3,624
Provisions (242) (44)
Other non current liabilites (81) (8)
Contract liabilities (2,353) (598)
Net cash flow from operating activities 21,057 18,517
Investing activities    
Purchase of property and equipment (Note 7) (1,868) (1,133)
Development costs (Note 10) (3,237) (1,551)
Business combinations, net of cash and cash equivalents acquired (Note 20) (50,712) (105,562)
Net cash flows used in investing activities (55,817) (108,246)
Financing activities    
Proceeds from operating facility and loan (Note 15) 45,000 52,500
Repayments of operating facility and loan (Note 15) (15,338) (14,588)
Repayment of right-of-use lease obligation (Note 8) (3,407) (2,605)
Payment of consideration payable (Note 14) (1,421)  
Issuance of common shares through short form prospectus, net (Note 17(i))   56,295
Issuance of common shares for stock options exercised (Note 17(i)) 532 228
Net cash flows from financing activities 25,366 91,830
(Decrease) increase in cash and cash equivalents (9,394) 2,101
Cash and cash equivalents, beginning of the period 22,096 19,995
Cash and cash equivalents, end of the period $ 12,702 $ 22,096